Executive record

Jonathan Poole

Most recent record: Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr. (named as the incoming officer), effective January 1, 2027.

1 verified record · 1 company

Career line from the records

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

2026-09-01TransitionVertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.
Named as the incoming officer, Executive Vice President and Chief Financial Officer
effective January 1, 2027 · 8-K filed September 1, 2026 · sec.gov, Item 5.02

Companies

Vertex PharmaceuticalsVRTX

Pharmaceutical Preparations

This page lists only verified filing records that name Jonathan Poole, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.